Contact information
Research groups
Colleges
Olu Onyimadu
DPhil
Senior Researcher in Health Economics
Olu Onyimadu is a Senior Researcher in Health Economics at the Nuffield Department of Primary Care Health Sciences, University of Oxford. His research focuses on the economic evaluation of health care interventions and the long-term health care costs of disease, with particular interests in obesity, child health and maternal health.
His doctoral research generated the first nationally representative estimates of childhood BMI transitions in the UK and the first England-specific estimates of NHS costs by childhood weight status. The latter attracted national media coverage, including BBC News. His research combines trial-based economic evaluation, cohort cost analysis, systematic review, cost-effectiveness modelling and econometric analysis of electronic health records to generate evidence that informs health policy and resource allocation.
He is Trial Health Economist on two NIHR-funded randomised controlled trials in maternal and child health, and his work has been cited by research groups internationally.
Olu holds an MSc in Health Economics and Decision Modelling from the University of Sheffield and a DPhil in Primary Health Care from the University of Oxford. Before joining Oxford, he worked in health technology assessment at the University of Southampton, supporting the development of evidence for NICE technology appraisals. Earlier in his career, he worked as a pharmacist in both clinical and industry settings.
Key publications
Protocol for a Group-Sequential Two-Stratum Multicenter Open-Label Randomized Clinical Trial of Respiratory Support in Infants With Acute Bronchiolitis: Breathing Assistance in Children With Bronchiolitis (BACHb).
Journal article
Johnson I. et al, (2025), Pediatr Crit Care Med, 26, e1275 - e1285
A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT
Journal article
Onyimadu O., (2021)
Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT
Journal article
Haldar S. et al, (2021)
Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial.
Journal article
Haldar S. et al, (2020), Eur Heart J, 41, 4471 - 4480
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Journal article
Picot J. et al, (2019), Pharmacoeconomics, 37, 753 - 762
Recent publications
Child Body Mass Index and Health Care Costs in England.
Journal article
Onyimadu O. et al, (2025), JAMA Netw Open, 8
Protocol for a Group-Sequential Two-Stratum Multicenter Open-Label Randomized Clinical Trial of Respiratory Support in Infants With Acute Bronchiolitis: Breathing Assistance in Children With Bronchiolitis (BACHb).
Journal article
Johnson I. et al, (2025), Pediatr Crit Care Med, 26, e1275 - e1285
Co-production and implementation of an evidence collation strategy for a novel point-of-care information resource: gpevidence.org.
Journal article
Treadwell J. et al, (2025), BMJ Evid Based Med
Childhood Transitions Between Weight Status Categories: Evidence from the UK Millennium Cohort Study.
Journal article
Onyimadu O. et al, (2024), Pharmacoeconomics, 42, 649 - 661
Psychometric Performance of Generic Childhood Multi-Attribute Utility Instruments in Preterm and Low Birthweight Populations: A Systematic Review
Journal article
Kwon J. et al, (2023), Children
